More epilepsy patients could have access to procedures involving Monteris Medical’s NeuroBlate system after a new coverage update from health insurance giant Aetna. The coverage update, which Monteris Medical announced today, involves Aetna’s medical policy for laser interstitial thermotherapy (LITT). It provides coverage for Aetna beneficiaries with refractory epilepsy who have met the established medical necessity criteria […]
Monteris Medical
Monteris wins FDA nod for NeuroBlate Optic laser probe
Monteris Medical said today it won FDA clearance for the NeuroBlate Optic laser probe designed for its minimally invasive magnetic resonance imaging-guided NeuroBlate robotic laser thermotherapy system, which is intended for use in treating brain tumors and epileptic foci. The Plymouth, Minn.-based company said that the newly cleared laser probe replaces previous generation’s metal thermocouple inside […]
FDA pulls select Monteris Medical NeuroBlate systems in Class I recall
The FDA today issued a recall for select Monteris Medical NeuroBlate systems and laser delivery probes over issues with unexpected MRI-related heating and damage to the tip of the probe that could cause serious injuries. The federal watchdog labeled the recall as a Class I, its most serious class of recall, which indicates the potential […]
Monteris Medical raises $27m Series C for NeuroBlate brain surgery device
Monteris Medical said yesterday that it raised a Series C round worth nearly $27 million it plans to use on R&D, clinical trials and expanding the commercial footprint of its NeuroBlate brain surgery device. Versant Ventures and SightLine Partners led the round, joined by prior backers Birchview Capital and BDC Capital’s Healthcare Venture Fund, Monteris said. The MRI-guided […]
Monteris Medical raises $7m for NeuroBlate
Monteris Medical raised nearly $7 million of a hoped-for $10 million debt-and-options round for the NeuroBlate neurosurgery device it’s developing. Plymouth, Minn.-based Monteris last month won FDA approval for an investigational device exemption trial of NeuroBlate in patients newly diagnosed with a form of brain cancer called glioblastoma multiforme. The MRI-guided device is designed to ablate, necrotize or coagulate […]
Monteris Medical wins FDA IDE nod for another NeuroBlate brain cancer trial
Monteris Medical said today it won FDA investigational device exemption to explore the use of its NeuroBlate system in patients newly diagnosed with glioblastoma multiforme. The NeuroBlate system is designed to ablate, necrotize or coagulate soft tissue during neurosurgery procedures through laser thermotherapy, and is not intended for any specific disease or lesion type, the company […]
Schellhorn out, Emerson in as Monteris CEO | Personnel Moves July 25, 2016
Schellhorn out, Emerson in as Monteris CEO Monteris Medical said last week it tapped ex-Galil Medical prez & CEO Martin Emerson as its new president and chief executive officer, replacing John Schellhorn who left earlier this year. Emerson spent 8 years as prez & CEO of Galil Medical, which was acquired in June this year […]
Monteris wins FDA IDE clearance for NeuroBlate trial
Monteris Medical said today it won FDA investigational device exemption clearance for a trial of its NeuroBlate system for treating medically refractory epilepsy. The NeuroBlate system is designed to ablate, necrotize or coagulate soft tissue during neurosurgery procedures through laser thermotherapy, and is not intended for any specific disease or lesion type, the company said. The […]
Monteris Medical expands to new HQ in Minn.
Monteris Medical said today it is opening a new facility that will act as its headquarters in Plymouth, Minn. on Wednesday this week. Plymouth Mayor Kelli Slavik will host a ribbon cutting event for the new facility, followed by a speech from Monteris CEO John Schellhorn and a tour of the new facility. “As part of […]
Monteris touts laser ablation study data
Monteris Medical said yesterday that data from a new study of its NeuroBlate minimally invasive robotic laser thermotherapy tool showed improved outcomes for patients undergoing procedures with the device. The findings were presented at the Congress of Neurological Surgeons annual meeting in New Orleans. The NeuroBlate system is an FDA-cleared device designed to ablate, necrotize […]
McGuire to take reins at Second Sight, Greenberg heads board | Personnel Moves
Second Sight Medical‘s (NSDQ:EYES) newly appointed CEO Will McGuire is set to take the reins starting August 18, the company said. Announced in June, former CEO Dr. Robert Greenberg will become chairman of the board at Second Sight, replacing Alfred Mann who will become chairman emeritus, according to the Sylmar, Calif.-based ‘bionic eye’-developing company. “Will […]